BIOPX
Price
$48.32
Change
-$1.50 (-3.01%)
Updated
Feb 21 closing price
Net Assets
1.6B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BIOPX vs GFACX

Header iconBIOPX vs GFACX Comparison
Open Charts BIOPX vs GFACXBanner chart's image
Baron Opportunity Retail
Price$48.32
Change-$1.50 (-3.01%)
VolumeN/A
Net Assets1.6B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BIOPX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIOPX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOPX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BIOPX (1.6B). BIOPX (0.00) and GFACX (0.00) have matching dividends . BIOPX was incepted earlier than GFACX: BIOPX (25 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. BIOPX (23.29). GFACX has a lower initial minimum investment than BIOPX: GFACX (250) vs BIOPX (2000). BIOPX annual gain was more profitable for investors over the last year : 23.30 vs. GFACX (10.15). BIOPX return over 5 years is better than : 83.17 vs. GFACX (32.83).
BIOPXGFACXBIOPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years24 years-
Gain YTD2.5252.98085%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B304B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.3010.15230%
Returns for 3 years48.4017.69274%
Returns for 5 years83.1732.83253%
Returns for 10 years155.6655.63280%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding